Inactive Instrument

Press Releases Adamas Pharmaceuticals, Inc.

Equities

ADMS

US00548A1060

Press Releases

Unlock all the news: Be the first to know and act before the market!

Adamas Pharmaceuticals : Completion of Acquisition or Disposition of Assets - Form 8-K	21-11-24	PU
ADAMAS PHARMACEUTICALS INC : Completion of Acquisition or Disposition of Assets, Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Material Modification to Rights of Security Holders, Changes in Control or Registrant, Change in Directors or Principal Officers, Amendments to Articles of Inc. or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits (form 8-K)	21-11-24	AQ
Supernus Pharmaceuticals Announces Expiration of Hart-Scott-Rodino Waiting Period for Adamas Pharmaceuticals Tender Offer	21-11-23	AQ
Adamas: Q3 Earnings Snapshot	21-11-11	AQ
ADAMAS PHARMACEUTICALS INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	21-11-10	AQ
ADAMAS PHARMACEUTICALS INVESTOR ALERT By the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Adamas Pharmaceuticals, Inc. - ADMS	21-10-12	BU
Adamas Pharmaceuticals : Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio - Form 8-K	21-10-12	PU
ADAMAS PHARMACEUTICALS INC : Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits (form 8-K)	21-10-12	AQ
Adamas Pharmaceuticals : Supernus Pharmaceuticals to Acquire Adamas Pharmaceuticals Strengthening its CNS Product Portfolio	21-10-11	AQ
Adamas Pharmaceuticals : Announces New Employment Inducement Grants	21-10-08	BU
Adamas Pharmaceuticals : Named 2021 Finalist in the New Therapeutics Category of the UCSF Health Awards	21-10-01	BU
Adamas Pharmaceuticals : Announces GOCOVRI Presentations at the Upcoming International Parkinson and Movement Disorder Society’s (MDS) Congress	21-09-16	BU
Adamas Pharmaceuticals : Announces New Employment Inducement Grants	21-09-10	BU
Adamas Pharmaceuticals : to Present at Upcoming September Investor Conferences	21-08-30	BU
Adamas Pharmaceuticals : Announces New Employment Inducement Grant	21-08-13	BU
Adamas: Q2 Earnings Snapshot	21-08-09	AQ
ADAMAS PHARMACEUTICALS INC : Results of Operations and Financial Condition (form 8-K)	21-08-09	AQ
ADAMAS PHARMACEUTICALS : MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	21-08-09	AQ
Adamas Pharmaceuticals : Reports Second Quarter 2021 Financial Results	21-08-09	BU
Adamas Pharmaceuticals : to Announce Second Quarter Financial Results and Host Conference Call on August 9, 2021	21-08-02	BU

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases Adamas Pharmaceuticals, Inc.

Equities

ADMS

US00548A1060

Press Releases

Filters